Percutaneous Coronary Intervention With Bare Metal Stents And Oral Sirolimus Has Comparable Safety And Efficacy To Treatment With Drug Eluting Stents But With Significant Lower Cost: 31 Months Cost Saving And Clinical Events Analysis From The Randomized, Controlled Orar Iii (Oral Rapamycin In Argentina) Study